Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:20 PM
Ignite Modification Date:
2025-12-24 @ 5:20 PM
NCT ID:
NCT07049250
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of lung cancer confirmed according to the Chinese Quality Control Indicators for Standardized Diagnosis and Treatment of Primary Lung Cancer (2022) through both imaging and histopathological examination.
* TNM staging determined using the 8th edition AJCC/UICC classification system.
* Scheduled to receive chemotherapy with an expected survival exceeding one year.
* Demonstrated normal cognitive and communication abilities as assessed by standardized neuropsychological tests.
* Provided written informed consent prior to enrollment.
Exclusion Criteria:
* Pre-existing neurological disorders.
* Significant organ dysfunction (defined as Child-Pugh class B/C for liver function or eGFR \<30 mL/min/1.73m² for renal function).
* Active infectious diseases.
* Contraindications to chemotherapy.
* Concurrent radiotherapy.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT07049250
Study Brief:
Protocol Section:
NCT07049250